These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29749400)

  • 1. GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML.
    Al Seraihi AF; Rio-Machin A; Tawana K; Bödör C; Wang J; Nagano A; Heward JA; Iqbal S; Best S; Lea N; McLornan D; Kozyra EJ; Wlodarski MW; Niemeyer CM; Scott H; Hahn C; Ellison A; Tummala H; Cardoso SR; Vulliamy T; Dokal I; Butler T; Smith M; Cavenagh J; Fitzgibbon J
    Leukemia; 2018 Nov; 32(11):2502-2507. PubMed ID: 29749400
    [No Abstract]   [Full Text] [Related]  

  • 2. Donor-derived MDS/AML in families with germline
    Galera P; Hsu AP; Wang W; Droll S; Chen R; Schwartz JR; Klco JM; Arai S; Maese L; Zerbe C; Parta MJ; Young NS; Holland SM; Hickstein DD; Calvo KR
    Blood; 2018 Nov; 132(18):1994-1998. PubMed ID: 30232126
    [No Abstract]   [Full Text] [Related]  

  • 3. GATA2 mutations in sporadic and familial acute myeloid leukaemia patients with CEBPA mutations.
    Green CL; Tawana K; Hills RK; Bödör C; Fitzgibbon J; Inglott S; Ancliff P; Burnett AK; Linch DC; Gale RE
    Br J Haematol; 2013 Jun; 161(5):701-705. PubMed ID: 23560626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of a compound in-cis GATA2 germline mutation in a pedigree presenting with myelodysplastic syndrome/acute myeloid leukemia with concurrent thrombocytopenia.
    Hahn CN; Brautigan PJ; Chong CE; Janssan A; Venugopal P; Lee Y; Tims AE; Horwitz MS; Klingler-Hoffmann M; Scott HS
    Leukemia; 2015 Aug; 29(8):1795-7. PubMed ID: 25676417
    [No Abstract]   [Full Text] [Related]  

  • 5. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature.
    Kazenwadel J; Secker GA; Liu YJ; Rosenfeld JA; Wildin RS; Cuellar-Rodriguez J; Hsu AP; Dyack S; Fernandez CV; Chong CE; Babic M; Bardy PG; Shimamura A; Zhang MY; Walsh T; Holland SM; Hickstein DD; Horwitz MS; Hahn CN; Scott HS; Harvey NL
    Blood; 2012 Feb; 119(5):1283-91. PubMed ID: 22147895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High penetrance of myeloid neoplasia with diverse clinical and cytogenetic features in three siblings with a familial GATA2 deficiency.
    Ellingford JM; Telford N; Urquhart J; Will AM; Bonney D; Adams B; Dixon R; Kerr B; Black GC; Wynn RF; Meyer S
    Cancer Genet; 2021 Aug; 256-257():77-80. PubMed ID: 33957466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations.
    McReynolds LJ; Yang Y; Yuen Wong H; Tang J; Zhang Y; Mulé MP; Daub J; Palmer C; Foruraghi L; Liu Q; Zhu J; Wang W; West RR; Yohe ME; Hsu AP; Hickstein DD; Townsley DM; Holland SM; Calvo KR; Hourigan CS
    Leuk Res; 2019 Jan; 76():70-75. PubMed ID: 30578959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic heterogeneity associated with germline
    Haddox CL; Carr RM; Abraham RS; Perez Botero J; Rodriguez V; Pardanani A; Patnaik MM
    Leuk Lymphoma; 2019 Dec; 60(13):3282-3286. PubMed ID: 31246134
    [No Abstract]   [Full Text] [Related]  

  • 9. Monozygotic twins with shared de novo GATA2 mutation but dissimilar phenotypes due to differential promoter methylation.
    Kim N; Choi S; Kim SM; Lee AC; Im K; Park HS; Kim JA; Kim K; Kim I; Chang YH; Lee DS
    Leuk Lymphoma; 2019 Apr; 60(4):1053-1061. PubMed ID: 30714451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia.
    Pasquet M; Bellanné-Chantelot C; Tavitian S; Prade N; Beaupain B; Larochelle O; Petit A; Rohrlich P; Ferrand C; Van Den Neste E; Poirel HA; Lamy T; Ouachée-Chardin M; Mansat-De Mas V; Corre J; Récher C; Plat G; Bachelerie F; Donadieu J; Delabesse E
    Blood; 2013 Jan; 121(5):822-9. PubMed ID: 23223431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of the GATA2 and CEBPA genes in paediatric acute myeloid leukaemia.
    Shiba N; Funato M; Ohki K; Park MJ; Mizushima Y; Adachi S; Kobayashi M; Kinoshita A; Sotomatsu M; Arakawa H; Tawa A; Horibe K; Tsukimoto I; Hayashi Y
    Br J Haematol; 2014 Jan; 164(1):142-5. PubMed ID: 24033149
    [No Abstract]   [Full Text] [Related]  

  • 12. Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival.
    Bödör C; Renneville A; Smith M; Charazac A; Iqbal S; Etancelin P; Cavenagh J; Barnett MJ; Kramarzová K; Krishnan B; Matolcsy A; Preudhomme C; Fitzgibbon J; Owen C
    Haematologica; 2012 Jun; 97(6):890-4. PubMed ID: 22271902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group.
    Theis F; Corbacioglu A; Gaidzik VI; Paschka P; Weber D; Bullinger L; Heuser M; Ganser A; Thol F; Schlegelberger B; Göhring G; Köhne CH; Germing U; Brossart P; Horst HA; Haase D; Götze K; Ringhoffer M; Fiedler W; Nachbaur D; Kindler T; Held G; Lübbert M; Wattad M; Salih HR; Krauter J; Döhner H; Schlenk RF; Döhner K
    Leukemia; 2016 Nov; 30(11):2248-2250. PubMed ID: 27375010
    [No Abstract]   [Full Text] [Related]  

  • 14. GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution.
    Hou HA; Lin YC; Kuo YY; Chou WC; Lin CC; Liu CY; Chen CY; Lin LI; Tseng MH; Huang CF; Chiang YC; Liu MC; Liu CW; Tang JL; Yao M; Huang SY; Ko BS; Hsu SC; Wu SJ; Tsay W; Chen YC; Tien HF
    Ann Hematol; 2015 Feb; 94(2):211-21. PubMed ID: 25241285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia.
    Hahn CN; Chong CE; Carmichael CL; Wilkins EJ; Brautigan PJ; Li XC; Babic M; Lin M; Carmagnac A; Lee YK; Kok CH; Gagliardi L; Friend KL; Ekert PG; Butcher CM; Brown AL; Lewis ID; To LB; Timms AE; Storek J; Moore S; Altree M; Escher R; Bardy PG; Suthers GK; D'Andrea RJ; Horwitz MS; Scott HS
    Nat Genet; 2011 Sep; 43(10):1012-7. PubMed ID: 21892162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial predisposition of myeloid malignancies: biological and clinical significance of recurrent germ line mutations.
    Matsui H
    Int J Hematol; 2017 Aug; 106(2):160-162. PubMed ID: 28631176
    [No Abstract]   [Full Text] [Related]  

  • 17. Heterogeneity of GATA2-related myeloid neoplasms.
    Hirabayashi S; Wlodarski MW; Kozyra E; Niemeyer CM
    Int J Hematol; 2017 Aug; 106(2):175-182. PubMed ID: 28643018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful umbilical cord blood hematopoietic stem cell transplantation in pediatric patients with MDS/AML associated with underlying GATA2 mutations: two case reports and review of literature.
    Mallhi K; Dix DB; Niederhoffer KY; Armstrong L; Rozmus J
    Pediatr Transplant; 2016 Nov; 20(7):1004-1007. PubMed ID: 27416790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA2 mutations lead to MDS and AML.
    Hyde RK; Liu PP
    Nat Genet; 2011 Sep; 43(10):926-7. PubMed ID: 21956389
    [No Abstract]   [Full Text] [Related]  

  • 20. Epigenetic regulation of GATA2 and its impact on normal karyotype acute myeloid leukemia.
    Celton M; Forest A; Gosse G; Lemieux S; Hebert J; Sauvageau G; Wilhelm BT
    Leukemia; 2014 Aug; 28(8):1617-26. PubMed ID: 24514424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.